Skip to content
Wenlo
Sign in
← Markets

Brainstorm Cell Therapeutics Inc.

Jacob A Frenkel (Director) reports BCLI insider transactions

4BCLIFiled Jul 28, 2026, 1:01 PM ET· Period Jul 24, 2026

About this filing

Brainstorm Cell Therapeutics Inc. (BCLI) filed Form 4 (insider transaction) with the SEC on Jul 28, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
Jacob A Frenkel · Director
DateTransactionSharesPriceValueHeld afterOwnership
Jul 24, 2026A · grantFootnotes F1+100,000$0.00$0.00343,777Direct
Footnotes
  1. F1 Represents shares of restricted stock units ("RSUs") issued pursuant to a Consulting Agreement dated July 24, 2026 between the Reporting Person and the Issuer (the "Consulting Agreement") and subject to the 2014 Global Share Option Plan. The RSUs shall vest as to (i) 50% of the award on October 24, 2026, and (ii) the remaining 50% of the award on April 24, 2027, provided that the Reporting Person continues to provide services to the Issuer pursuant to the Consulting Agreement through each applicable vesting date.

More BCLI filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.